Outset Medical (OM) Net Margin (2019 - 2026)

Outset Medical (OM) has 8 years of Net Margin data on file, last reported at 68.11% in Q1 2026.

• On a quarterly basis, Net Margin rose 1855.0% year-over-year to 68.11% in Q1 2026; TTM through Mar 2026 was 63.65%, a 3508.0% increase from a year earlier, with the FY2025 full-year figure at 68.34%, up 4422.0% from the prior year.
• Net Margin for Q1 2026 stood at 68.11%, down from 67.5% in the prior quarter.
• Over the last five years, Net Margin for OM reached as high as 59.01% in Q2 2025 and fell as low as 174.96% in Q2 2022.
• Historically, Net Margin has averaged 111.66% across 5 years, with a median of 122.21% in 2023.
• Across the five-year window, Net Margin tumbled 5516 bps in 2022 and surged 6679 bps in 2025, its largest moves.
• Year by year, Net Margin stood at 129.48% in 2022, then grew by 2 bps to 126.53% in 2023, then soared by 31 bps to 87.01% in 2024, then increased by 22 bps to 67.5% in 2025, then slipped by 1 bps to 68.11% in 2026.
• Per Business Quant data, the three most recent Net Margin figures were 68.11% in Q1 2026, 67.5% in Q4 2025, and 60.61% in Q3 2025.